According to reports, Carlyle is considering a bid for the British shoemaker that would value that brand at more than £1m. Currently owned by European buyout specialist Permira, Dr Martens enjoyed an EBITDA profit increase of 70% last year.
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.